Rain Financial Statements From 2010 to 2024

RAINDelisted Stock  USD 1.41  0.01  0.70%   
Rain Therapeutics financial statements provide useful quarterly and yearly information to potential Rain Therapeutics investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Rain Therapeutics financial statements helps investors assess Rain Therapeutics' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Rain Therapeutics' valuation are summarized below:
Rain Therapeutics does not presently have any trending fundamental ratios for analysis.
Check Rain Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Rain Therapeutics' main balance sheet or income statement drivers, such as , as well as many indicators such as . Rain financial statements analysis is a perfect complement when working with Rain Therapeutics Valuation or Volatility modules.
  
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

Rain Therapeutics Company Return On Equity Analysis

Rain Therapeutics' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Return On Equity

 = 

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current Rain Therapeutics Return On Equity

    
  -0.97  
Most of Rain Therapeutics' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Rain Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition

Based on the latest financial disclosure, Rain Therapeutics has a Return On Equity of -0.9704. This is 95.95% lower than that of the Biotechnology sector and 97.34% lower than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.

Rain Therapeutics Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Rain Therapeutics's current stock value. Our valuation model uses many indicators to compare Rain Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Rain Therapeutics competition to find correlations between indicators driving Rain Therapeutics's intrinsic value. More Info.
Rain Therapeutics is rated fifth in return on equity category among its peers. It also is rated fifth in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Rain Therapeutics' earnings, one of the primary drivers of an investment's value.

About Rain Therapeutics Financial Statements

Rain Therapeutics investors utilize fundamental indicators, such as revenue or net income, to predict how Rain Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Rain Therapeutics Inc., a clinical-stage precision oncology company, engages in developing therapies that target oncogenic drivers in the United States. Rain Therapeutics Inc. was incorporated in 2017 and is headquartered in Newark, California. Rain Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 44 people.

Pair Trading with Rain Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Rain Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rain Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving together with Rain Stock

  0.63VFSWW VinFast AutoPairCorr

Moving against Rain Stock

  0.84CAT Caterpillar Fiscal Year End 3rd of February 2025 PairCorr
  0.84AA Alcoa Corp Fiscal Year End 15th of January 2025 PairCorr
  0.8HPQ HP IncPairCorr
  0.79CSCO Cisco Systems Aggressive PushPairCorr
  0.72XOM Exxon Mobil Corp Sell-off TrendPairCorr
The ability to find closely correlated positions to Rain Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Rain Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Rain Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Rain Therapeutics to buy it.
The correlation of Rain Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Rain Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Rain Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Rain Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Consideration for investing in Rain Stock

If you are still planning to invest in Rain Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Rain Therapeutics' history and understand the potential risks before investing.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Share Portfolio
Track or share privately all of your investments from the convenience of any device